You have 9 free searches left this month | for more free features.

Tazarotene

Showing 1 - 25 of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Scalp Psoriasis Trial in Karachi (Tazarotene 0.045% Topical Application Lotion [ARAZLO])

Completed
  • Scalp Psoriasis
  • Tazarotene 0.045% Topical Application Lotion [ARAZLO]
  • Karachi, Sindh, Pakistan
    JPMC
Aug 28, 2023

Psoriasis Vulgaris Trial in High Point (0.01% Halobetasol, 0.045% Tazarotene, 0.05% Clobetasol Propionate)

Active, not recruiting
  • Psoriasis Vulgaris
  • 0.01% Halobetasol
  • +2 more
  • High Point, North Carolina
    Dermatology Consulting Services, PLLC
Sep 16, 2023

Solid Tumor, Hand-Foot Skin Reaction (HFSR) Trial in Boston (Topical Tazarotene, Placebo)

Terminated
  • Solid Tumor
  • Hand-Foot Skin Reaction (HFSR)
  • Topical Tazarotene
  • Placebo
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 5, 2022

Scalp Psoriasis Trial in High Point (0.045% Tazarotene/0.01% Halobetasol Lotion)

Recruiting
  • Scalp Psoriasis
  • 0.045% Tazarotene/0.01% Halobetasol Lotion
  • High Point, North Carolina
    Dermatology Consulting Services, PLLC
May 14, 2023

Acne Vulgaris, Post Inflammatory Hyperpigmentation, Post Inflammatory Pigmentation Change Trial in Boston (Tazarotene 0.045%

Completed
  • Acne Vulgaris
  • +4 more
  • Tazarotene 0.045% Lotion
  • Boston, Massachusetts
    The Dermatology Institute of Boston
Jan 19, 2023

Acne Scar Trial in Karachi (Tazarotene gel 0.1%, Microneedling)

Completed
  • Acne Scar
  • Tazarotene gel 0.1%
  • Microneedling
  • Karachi, Sindh, Pakistan
    Jinnah Post graduate medical center
Oct 11, 2022

Warts Flat Trial in Zagazig (Tazarotene 0.1% Gel,Top, Imiquimod, Fluorouracil Cream)

Recruiting
  • Warts Flat
  • Tazarotene 0.1% Gel,Top
  • +3 more
  • Zagazig, Select Region, Egypt
    Dermatology department, Zagazig University Hospitals, Faculty of
May 12, 2022

Plaque Psoriasis Trial in Charlotte (Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%, Duobrii® Lotion (Halobetasol

Completed
  • Plaque Psoriasis
  • Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%
  • +2 more
  • Charlotte, North Carolina
    Catawba Research, LLC
Mar 15, 2022

Psoriasis Trial (308nm Excimer laser, Tazarotene Topical Gel, Betamethasone Valerate)

Not yet recruiting
  • Psoriasis
  • 308nm Excimer laser
  • +2 more
  • (no location specified)
Oct 15, 2022

Acne Keloidalis Nuchae, AKN Trial in New York (Duobrii, Placebo, Bryhali)

Recruiting
  • Acne Keloidalis Nuchae
  • AKN
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 1, 2022

Acne Vulgaris Trial in United States (Adapalene Gel, 0.1%, Tazarotene Cream, 0.1%, Adapalene Gel, 0.1% + Tazarotene Cream, 0.1%)

Completed
  • Acne Vulgaris
  • Adapalene Gel, 0.1%
  • +2 more
  • San Diego, California
  • +11 more
Jul 28, 2022

Palmoplantar Psoriasis, Plaque Psoriasis Trial in New York (Duobrii®)

Recruiting
  • Palmoplantar Psoriasis
  • Plaque Psoriasis
  • New York, New York
    Mount Sinai Downtown Union Square
Apr 19, 2021

Acne Vulgaris Trial in Austin (Tazarotene Lotion, 0.1%, Tazarotene Cream, 0.1%)

Completed
  • Acne Vulgaris
  • Tazarotene Lotion, 0.1%
  • Tazarotene Cream, 0.1%
  • Austin, Texas
  • +1 more
Feb 4, 2021

Neoplastic Syndrome Trial in Oakland, New York (tazarotene)

Completed
  • Neoplastic Syndrome
  • tazarotene
  • Oakland, California
  • +1 more
Oct 8, 2020

Acne Vulgaris Trial in Fremont (DFD-03 (0.1% tazarotene) Lotion, DFD-03 (0% tazarotene) Lotion (Placebo))

Completed
  • Acne Vulgaris
  • DFD-03 (0.1% tazarotene) Lotion
  • DFD-03 (0% tazarotene) Lotion (Placebo)
  • Fremont, California
    Center for Dermatology Clinical Research Inc.
Feb 4, 2021

Acne Vulgaris Trial in Miami (DFD-03 Lotion, 0.1%, Tazorac Cream, 0.1%, DFD-03 Vehicle Lotion 0%)

Completed
  • Acne Vulgaris
  • DFD-03 Lotion, 0.1%
  • +3 more
  • Miami, Florida
    International Dermatology Inc.
Aug 13, 2020

Acne Vulgaris Trial in Belize, United States (Tazarotene (Fabior™), Tazarotene (Actavis), Vehicle foam)

Completed
  • Acne Vulgaris
  • Tazarotene (Fabior™)
  • +2 more
  • Encino, California
  • +14 more
May 29, 2020

Acne Vulgaris Trial in Plano (DFD-03, Placebo Comparator)

Completed
  • Acne Vulgaris
  • Plano, Texas
    Dr. Seemal
Feb 4, 2021

Acne Vulgaris Trial in United States (IDP-123 Lotion, Tazorac Cream, Vehicle Lotion)

Completed
  • Acne Vulgaris
  • IDP-123 Lotion
  • +3 more
  • Encinitas, California
  • +15 more
Sep 3, 2020

Acne Vulgaris Trial in United States (CD5789 25 µg/g cream, CD5789 50 µg/g cream, CD5789 100 µg/g cream)

Completed
  • Acne Vulgaris
  • CD5789 25 µg/g cream
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 23, 2021

Sun-Damaged Skin, Retinoid Intolerance Trial in Ann Arbor (Tazorac, Dove Mild Cleanser, Dove Facial Moisturizer)

Completed
  • Sun-Damaged Skin
  • Retinoid Intolerance
  • Ann Arbor, Michigan
    University of Michigan Department of Dermatology
Mar 11, 2020

Psoriasis Trial in Salt Lake City (Acitretin 25Mg Oral Capsule, Excimer laser, Tazarotene 0.1% Gel,Top)

Terminated
  • Psoriasis
  • Acitretin 25Mg Oral Capsule
  • +3 more
  • Salt Lake City, Utah
    University of Utah Department of Dermatology
Jun 6, 2019

Psoriasis Trial in United States (IDP-118 Lotion, Tazorac Cream, IDP-118 Vehicle Lotion)

Completed
  • Psoriasis
  • IDP-118 Lotion
  • +3 more
  • Encino, California
  • +13 more
Aug 8, 2020

Acne Vulgaris Trial in Dripping Springs, Pflugerville (Isotretinoin, Amzeeq 4% Topical Foam)

Active, not recruiting
  • Acne Vulgaris
  • Dripping Springs, Texas
  • +1 more
Mar 22, 2022

Keratosis Pilaris Trial in Dayton (Salkera Emollient Foam)

Terminated
  • Keratosis Pilaris
  • Salkera Emollient Foam
  • Dayton, Ohio
    Wright State University School of Medicine, Department of Dermat
Feb 3, 2022